The annual incidence of reported giardiasis in the United States decreased. This study found that decreases differ by age group and sex and may reflect either changes in surveillance methods or changes in exposure. From 1995From -2016, the average number of reported cases were 19 781 per year (range 14 623-27 778 cases). The annual incidence of reported giardiasis in the US decreased across all age groups. This decrease differs by age group and sex and may reflect either changes in surveillance methods (for example changes to case definitions or reporting practices) or changes in exposure.
Introduction
Giardia duodenalis (also known as G. lamblia and G. intestinalis) is one of the most common intestinal parasites in humans, with one million estimated giardiasis cases annually in the United States [1, 2] . Giardiasis is typically characterized by acute gastrointestinal illness presenting as diarrhea with or without abdominal cramping and bloating, flatulence, malabsorption and weight loss. Symptoms can persist for weeks and are highly variable depending on the susceptibility of the host, strain genotype and pathogen virulence. Infected individuals can be asymptomatic or experience a mild, self-limiting illness. Less frequently, in adults, severe illness and/or chronic sequelae occur, including irritable bowel syndrome [3] , chronic fatigue [4] , post-infectious arthritis or joint pain [5, 6] . Chronic sequelae in infants and children can include failure to thrive and malnutrition [7] . If identified early, giardiasis can usually be treated simply with anti-giardial drugs minimizing post-infectious and long-term sequelae [8] .
Transmission of giardiasis occurs through waterborne, person-to-person and foodborne sources.
Infection occurs indirectly or directly via ingestion of contaminated water and food, or through person-to-person contact via the fecal-oral route [9] . This range of transmission pathways can make identification of the exposure source of individual cases or outbreaks challenging. At-risk individuals include those in close contact with infected persons, such as other children in child care settings, their family members and caregivers [10, 11] . Giardiasis is frequently diagnosed in international travellers returning from areas that have poor sanitation [12] and in internationally adopted children [13] . There is growing evidence of giardiasis transmission among men who have sex with men (MSM) through fecal-oral contact during sexual activity [14, 15] . Improvements in molecular technology for characterization of Giardia suggest that zoonotic transmission, including from household pets, is less common than other transmission pathways [16] .
Giardiasis is a common cause of outbreaks of waterborne gastrointestinal illness associated with drinking water and treated and untreated recreational water sources [17] [18] [19] [20] . Transmission of giardiasis via water is facilitated by several factors, including the chlorine-tolerance of Giardia cysts, their immediate infectiousness, protracted and intermittent shedding of Giardia protozoa by individuals who may be asymptomatic or experience a mild infection, and the low dose required for infection [21, 22] . Foodborne outbreaks of giardiasis caused by contamination from food handlers, animals, or irrigation practices are less common [23, 24] . 
Methods

Data
State-level giardiasis case data were obtained from NNDSS for the period 1995-2016. The number of health departments submitting can vary from year to year depending on which states have designated giardiasis as reportable in their jurisdictions. National giardiasis reporting by states varied with several not reportable each year and therefore not notified to CDC. Specifically, each year in this analysis, at least 4 states and up to 9 states did not report giardiasis cases. Giardiasis was not reportable in Texas and North Carolina during the study period. NNDSS case data include year of report; whether the case was reported as associated with an outbreak; case-patient's state of 6 residence; race; ethnicity; sex; age; and classified case status (i.e. whether the case met criteria of the national case definition for confirmed or non-confirmed classification (https://wwwn.cdc.gov/nndss/conditions/giardiasis/case-definition/2011/) [26] . Case status was dichotomized into confirmed and non-confirmed cases (probable, suspect and unknown). Age was categorized into eight groups: 0-4, 5-9, 10-19, 20-29, 30-39, 40-49, 50-64 and ≥65 years. Case counts were examined by year and aggregated into three time periods (1995-2001, 2002-2009 and 2011-2016) to simplify analysis and presentation, guided by changes in notification practices and case definitions.
Analysis
NNDSS data for 1995-2016 were analyzed using Stata, version 14.1 (StataCorp, College Station, TX, USA). Initial descriptive analysis included calculation of crude annual incidence rates (cases per 100 000 population) using each year's mid-year census estimate as denominators. Rates were examined by year, age group, sex, US state, and census region (Northeast, Midwest, South and West). Maps were created to display rates of giardiasis by state across three time periods (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) and 2011-2016), using ArcGIS version 10.3 (ESRI, USA). Average reported giardiasis incidence rates per 100 000 population for these three time periods were calculated by combining case counts and mid-year census estimates. There were nine states that did not report for at least one year between 1995 and 2016. Non-reporting states were removed from census estimates for the non-reporting year only.
To examine trends in binomial proportions of case status, sex, race and ethnicity over time, a test for trend was used. The hypothesis was that there were no changes in proportion of non-confirmed, male, white or non-Hispanic cases over time. We then used count response models to examine changes in giardiasis rates during the time period, overall and by age group and sex. Negative binomial regression was used to model counts because the data were over-dispersed. Model results were summarized as predicted incidence rate ratios (IRR) and 95% confidence intervals (CI) to compare modelled rates across the time periods. Multivariable models were constructed with selected variables to assess possible interactions as well as the independent effects. The base regression model included age group, sex and year period. The full model added interactions between age group and year period, age group and sex, and sex and year period. The difference between the base and full models were evaluated using a likelihood ratio test. per 100 000) and 2013-2016 (range 5.7-6.3 per 100 000) ( Figure B ). Crude incidence rates also varied over the time period of reporting by individual US states. In 1995, the annual rate of giardiasis ranged from 0.7 cases to as high as 53.5 cases per 100 000; however, by 2016, the range had reduced from 1.8 cases to 14.1 cases per 100 000 ( Figure 2 ). Over the time period, the highest numbers of giardiasis cases were reported by northern US states. Rates were consistently highest in the Northeast (10.9 cases per 100 000) and lowest in the South (6.1 cases per 100 000). The greatest reduction per region was observed in the West, which fell from 13.6 cases per 100 000 in 1995-2001 to 5.8 cases per 100 000 in 2011-2016. By state, rates were lowest in Louisiana (2.7 cases per 100 000) and highest in Vermont (35.1 cases per 100 000). In 1995, 32 of 44 reporting US jurisdictions had giardiasis rates higher than 10 cases per 100 000; however, by 2016, this number had reduced to 17 of 43 reporting jurisdictions.
Results
During the time period 1995-2016, the majority were reported in white (n = 205 198; 47.2%) and non-Hispanic giardiasis cases (n = 191 933; 44.1%); however, over half of case reports were missing race and ethnicity data. Nationally changing trends in sex distribution were observed. In 1995, 12 951 cases were male (51.3%) and 12 298 cases were female. By 2016, the proportion of male cases (60.1%) was significantly higher than female cases (X 2 = 1362.077, p <0.0001) ( Figure 3 ).
The highest giardiasis rates throughout the study period were observed in children aged 0-4 years and 5-9 years compared to other age groups (Figure 4 ). From 1995-2001, higher rates were seen in adults aged 30-39 years; however, by 2011-2016 the rate had decreased to become comparable to other adult age groups. Rates in those aged 10-19 and ≥65 years remained consistently lower than rates observed in all age groups during the time period.
Using count response models, the rate of decrease over time differed by age group ( Supplementary   Table S1 ). 
Discussion
We describe significant declines in the rates of reported giardiasis in the United States during 1995-2016. We observed considerable variations in the incidence of reported giardiasis cases between age groups, sex and among US states and jurisdictions. The higher incidence rates seen in children aged 0-4 years compared with other age groups might reflect minimal toileting skills, attendance at child care centers and greater immunologic susceptibility [27] . Persistently higher rates highlight the continued challenges of preventing and controlling giardiasis in young children. Children may transmit infection to household contacts or other children in crowded environments such as child care settings, and represent an important source of community infection [28] . Increased risk of giardiasis infection associated with children in diapers has been reported in the United States, and likely represents an important and frequently encountered risk factor [15] . Good diaper-handling hygiene in the home and child care settings may limit disease spread. Additionally, in child care settings, maintenance of infection control principles as well as support of ongoing staff training may limit disease spread [27, 29, 30] .
We found that males had significantly higher rates of illness, particularly later in the surveillance period. From 1995-2001, the distribution among males and females was relatively equal; however, during 2002-2010 and 2011-2016 the proportion of giardiasis cases in males was significantly higher. The higher incidence rates in males aged 10-49 years may reflect differing patterns of exposures to activities although this is difficult to assess, as standardized exposure data is not required to be reported by US states. The difference between males and females was most significant in individuals aged 40-49 years, followed by 30-39 years and 20-29 years. Enteric infections such as giardiasis can be transmitted during sexual activity where there is exposure to fecal material [14, [31] [32] [33] . Giardia has been documented among MSM and significant association between male-male sexual behavior reported [14, 15] . The potential contribution of this person-toperson transmission route to the differences observed between sexes needs to be further explored. It is known that giardiasis can be transmitted through untreated surface water. The implementation of national drinking water regulations for surface and ground water sources, changes in public water system management and practice, and general improvements to drinking water infrastructure may have contributed to a decrease in giardiasis outbreaks [25] . These changes include revisions to the US Environmental Protection Agency management practices under the Safe Drinking Water Act to address parasite contamination of surface water and improved water quality and safety following large waterborne outbreaks of chlorine-tolerant pathogens [34, 35] . Plateauing rates of giardiasis may indicate that private, unregulated water supplies could be an important route of transmission; evidence indicates US counties with high private-well reliance have higher giardiasis rates [36] . In most situations, private well owners are not legally compelled to test, treat or maintain their drinking water systems to any standard. The standardized collection of exposure information by US states on all giardiasis cases would increase information on risk factors and disease prediction.
Our analysis found higher rates were reported in the Northeast region. Explanations may include regional differences in giardiasis transmission [25] . Other explanations for the variation across states and regions include differences in laboratory detection practice and surveillance capacity. As noted previously, the number of US states who report giardiasis cases fluctuated over the period. There are many reasons states may decide not to include giardiasis on their list of reportable diseases including resource considerations, perceived lack of severity and relative importance with other enteric infections, and lack of diagnostic capabilities. Non-reporting states were dominated by those from the US southern region. Declining and plateauing rates across the time period may also be influenced by changing case definition criteria. Prior to the case definition change in 2011, all cases with laboratory evidence of giardiasis were classified as confirmed, regardless if the case met the clinical description [26] . The overall decrease in giardiasis rates, including in non-confirmed cases, may be due to the more precise case definition for national surveillance. Changes in the proportion of confirmed cases may also be due to variable diagnostic testing practices by US jurisdictions.
Declining giardiasis trends have also reported in communities in Canada and in New Zealand children [37, 38] . Other infectious gastrointestinal diseases such as cryptosporidiosis and rotavirus have reported variable patterns over time in the United States. From 2005-2012, a significant increase in cryptosporidiosis cases through the United States occurred, driven in part by large outbreaks [39] . In contrast, declines in the prevalence and altered seasonal patterns of rotavirus have occurred following the implementation of the rotavirus program [40] . Despite declining rates, giardiasis continues to be the most commonly reported intestinal parasite identified in the United States.
There are an estimated 1 459 emergency department visits and 2 833 hospitalizations of giardiasis annually, costing approximately $65 million [2] . In 2016, giardiasis reporting increased for the first time since 2010 coinciding with the introduction of molecular diagnostics for rapid and simultaneous detection of enteric pathogens; however, diagnostic testing data is unavailable to validate these trends. Accurate identification and diagnosis of enteric pathogens is required to appropriately manage and treat case symptoms, minimize long-term sequelae and in combination with accurate exposure information, control the spread of disease. Molecular diagnostics have provided new tools for detecting Giardia and have the potential to improve timeliness and detection of sporadic infections. Improved technologies can impact the number of cases identified and public health response [28] . Future research priorities will include investigating the impact of these changing diagnostic techniques on surveillance for giardiasis in the United States.
Our analysis is subject to some limitations, including under-reporting of infections due to asymptomatic presentation and carriage, failure by infected individuals to seek medical care, failure of medical staff to include giardiasis diagnostic testing in their evaluation and incomplete case report or laboratory reports forwarded to public health officials. Surveillance data used in this analysis was incomplete for race and ethnicity data which limits our information on different population subgroups [30] . Public health agencies report whether giardiasis cases are outbreak-associated without connection to separate outbreak reporting systems, which may under-capture the true proportion of outbreak-associated cases. Variability in surveillance capacity, reporting requirements and the number of reporting states may limit comparison of rates over time and between US states.
Conclusion
Giardiasis has declined significantly in the United States and the age and sex groups at highest risk have changed. Our findings should be used by federal, state and local public health agencies to guide and implement targeted evidence-based disease prevention strategies and research priorities for giardiasis. Further investigation is needed to explain the apparent plateau in rates between 2012 and 2015, if the increase in 2016 continues thereafter, higher and increasing reporting in males especially among certain age groups, variability in geographical distribution and how the increasing use of molecular diagnostics will influence the future notification and surveillance of giardiasis in the United States. Average incidence rate a of giardiasis cases per 100 000 population, by age group and year period, United States, 1995-2016. a N = 429 417 cases: missing age data for n = 5 770 (1.3%) cases.
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Figure 5.
Predicted incidence rate ratio for females versus males, by age group, United States, 1995-2016 
